Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan

World Journal of Gastroenterology

Volumn 19, Issue 27, 2013, Pages 4432-4436

  Lim, Darryl ^a   Lee, Ser Yee ^a,b,c   Lim, Kiat Hon ^a,c   Chan, Chung Yip ^a,b,c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Hepatic adenoma; Hepatocellular adenoma; Hepatocyte nuclear factor 1 ; Positron emission tomography

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1ALPHA;

ADULT; ARTICLE; CASE REPORT; CHOLECYSTECTOMY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LIVER ADENOMA; LIVER HISTOLOGY; LIVER METASTASIS; LYMPH NODE DISSECTION;

EID: 84880413172     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i27.4432     Document Type: Article

References (33)

1. Shiomi S, Kawabe J. Clinical applications of positron emission tomography in hepatic tumors. Hepatol Res 2011; 41: 611-617 [PMID: 21711419 DOI: 10.1111/j.1872-034X.2011.00819.x]
2. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK, Pinson CW. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 1998; 133: 510-55; discussion 510-515. [PMID: 9605913]
3. Reddy KR, Schiff ER. Approach to a liver mass. Semin Liver Dis 1993; 13: 423-435 [PMID: 8303323]
4. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242: 644-648 [PMID: 221698]
5. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H, Zucman-Rossi J, Balabaud C, Saric J. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50: 481-489 [PMID: 19585623 DOI: 10.1002/hep.22995]
6. Farges O, Dokmak S. Malignant transformation of liver adenoma: an analysis of the literature. Dig Surg 2010; 27: 32-38 [PMID: 20357449 DOI: 10.1159/000268405]
7. Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G. 'False-positive' uptake of FDG in a hepatic adenoma. Clin Nucl Med 1997; 22: 490-491 [PMID: 9227877]
8. Sumiyoshi T, Moriguchi M, Kanemoto H, Asakura K, Sasaki K, Sugiura T, Mizumo T, Uesaka K. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case. Surg Today 2012; 42: 200-204 [DOI: 10.1007/s00595-011-0067-7]
9. Fosse P, Girault S, Hoareau J, Testard A, Couturier O, Morel O. Unusual uptake of 18FDG by a hepatic adenoma. Clin Nucl Med 2013; 38: 135-136 [PMID: 23334131 DOI: 10.1097/ RLU.0b013e318279b95a]
10. Sanli Y, Bakir B, Kuyumcu S, Ozkan ZG, Gulluoglu M, Bilge O, Turkmen C, Mudun A. Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT. Clin Nucl Med 2012; 37: 697-698 [PMID: 22691518 DOI: 10.1097/ RLU.0b013e3182443ced]
11. Buc E, Dupre A, Golffier C, Chabrot P, Flamein R, Dubois A, Pezet D. Positive PET-CT scan in hepatocellular adenoma with concomitant benign liver tumors. Gastroenterol Clin Biol 2010; 34: 338-341 [PMID: 20227207 DOI: 10.1016/ j.gcb.2010.01.018]
12. Stephenson JA, Kapasi T, Al-Taan O, Dennison AR. Uptake of 18FDG by a Hepatic Adenoma on Positron Emission Tomography. Case Reports Hepatol 2011; 2011 [DOI: 10.1155/2011/276402]
13. Magini G, Farsad M, Frigerio M, Serra C, Colecchia A, Jovine E, Vivarelli M, Feletti V, Golfieri R, Patti C, Fanti S, Franchi R, Lodi F, Boschi S, Bernardi M, Trevisani F. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med 2009; 34: 659-665 [PMID: 19893396 DOI: 10.1097/RLU.0b013e3181b53488]
14. Walther Z, Jain D. Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int 2011; 2011: 403929 [PMID: 21559202 DOI: 10.4061/2011/403929]
15. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008; 48: 808-818 [PMID: 18688875 DOI: 10.1002/hep.22417]
16. van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, Ijzermans JN. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 2011; 261: 172-181 [PMID: 21875850 DOI: 10.1148/radiol.11110023]
17. Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics 2011; 31: 1529-1543 [PMID: 21997980 DOI: 10.1148/rg.316115527]
18. Lan BY, Kwee SA, Wong LL. Positron emission tomography in hepatobiliary and pancreatic malignancies: a review. Am J Surg 2012; 204: 232-241 [PMID: 22464445 DOI: 10.1016/ j.amjsurg.2011.07.025]
19. Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of primary hepatobiliary tumors, part 2jgnyan. AJR Am J Roentgenol 2011; 197: W260-W265 [PMID: 21785051 DOI: 10.2214/AJR]
20. Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H, Collins BT, Di Bisceglie AM. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000; 32: 792-797 [PMID: 10845666]
21. Wudel LJ, Delbeke D, Morris D, Rice M, Washington MK, Shyr Y, Pinson CW, Chapman WC. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg 2003; 69: 117-124; discussion 124-126 [PMID: 12641351]
22. Jeong YJ, Sohn MH, Lim ST, Kim DW, Jeong HJ, Chung MJ, Lee CS, Yim CY. 'Hot liver' on 18F-FDG PET/CT imaging in a patient with hepatosplenic tuberculosis. Eur J Nucl Med Mol Imaging 2010; 37: 1618-1619 [PMID: 20505934 DOI: 10.1007/s00259-010-1477-2]
23. Wang YT, Lu F, Zhu F, Qian ZB, Xu YP, Meng T. Primary hepatic tuberculoma appears similar to hepatic malignancy on F-18 FDG PET/CT. Clin Nucl Med 2009; 34: 528-529 [PMID: 19617736 DOI: 10.1097/RLU.0b013e3181abb6f7]
24. Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W, Ide M, Shohtsu A. 18F-FDG PET detection of colonic adenomas. J Nucl Med 2001; 42: 989-992 [PMID: 11438616]
25. Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, Takahashi Y, Mimori A. Whole-body FDGPET/ CT on rheumatoid arthritis of large joints. Ann Nucl Med 2009; 23: 783-791 [PMID: 19834653 DOI: 10.1007/ s12149-009-0305-x]
26. Nishizawa S, Inubushi M, Kido A, Miyagawa M, Inoue T, Shinohara K, Kajihara M. Incidence and characteristics of uterine leiomyomas with FDG uptake. Ann Nucl Med 2008; 22: 803-810 [PMID: 19039559 DOI: 10.1007/s12149-008-0184-6]
27. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005; 11: 183-190 [PMID: 15685173]
28. Kim YH, Kim JY, Jang SJ, Chung HW, Jang KS, Paik SS, Song SY, Choi YY. F-18 FDG uptake in focal fatty infiltration of liver mimicking hepatic malignancy on PET/CT images. Clin Nucl Med 2011; 36: 1146-1148 [PMID: 22064098 DOI: 10.1097/RLU.0b013e3182335f60]
29. Metser U, Miller E, Lerman H, Even-Sapir E. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence. AJR Am J Roentgenol 2007; 189: 1203-1210 [PMID: 17954662]
30. aumonier H, Cailliez H, Balabaud C, Possenti L, Zucman- Rossi J, Bioulac-Sage P, Trillaud H. Role of contrastenhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. AJR Am J Roentgenol 2012; 199: 341-348 [PMID: 22826395 DOI: 10.2214/AJR.11.7046]
31. Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 2012; 199: 26-34 [PMID: 22733890 DOI: 10.2214/AJR.11.7750]
32. Denecke T, Steffen IG, Agarwal S, Seehofer D, Kröncke T, Hänninen EL, Kramme IB, Neuhaus P, Saini S, Hamm B, Grieser C. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol 2012; 22: 1769-1775 [PMID: 22437921 DOI: 10.1007/s00330-012-2422-5]
33. van den Esschert JW, Bieze M, Beuers UH, van Gulik TM, Bennink RJ. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/ CT. Eur J Nucl Med Mol Imaging 2011; 38: 436-440 [PMID: 20717825 DOI: 10.1007/s00259-010-1584-0]